Several clinical studies have shown that thrombocytosis is a poor prognostic factor in some types of cancer, but data about the impact of thrombocytosis on prognosis in patients with colon cancer are very limited. We investigated the prevalence and prognostic effect of pre-operative thrombocytosis, defined as a platelet count > 400 × 109/l, retrospectively in patients with node-negative colon cancer. Out of 198 patients, 24 (12.1%) had thrombocytosis, and its presence correlated with tumour depth and lymphatic invasion. Univariate analysis revealed that disease-free survival and overall survival were shorter in patients with pre-operative thrombocytosis than those without thrombocytosis. On multivariate analysis, thrombocytosis alone retained significance as a poor prognostic factor for both disease-free survival and overall survival. In conclusion, this study shows an association between thrombocytosis and poor survival in patients with node-negative colon cancer. The pre-operative platelet count may help to identify patients with an unfavourable prognosis in this subgroup.
LiefersGJCleton-JansenAMvan de VeldeCJHermansJvan KriekenJHJMCornelisseCJ: Micrometastases and survival in stage II colorectal cancer. N Engl J Med1998; 339: 223–228.
4.
RiessL: Zur pathologischen anaotmie des blutes. Arch Anat Physiol Wissensch Med1872; 39: 237–249.
5.
NaschitzJEYeshurunDEldarSLevLM: Diagnosis of cancer-associated vascular disorders. Cancer1996; 77: 1759–1767.
LavieOComerciGDarasVBolgerBSLopesAMonaghanJM: Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol1999; 72: 82–86.
8.
GislasonTNouE: Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: An epidemiological study. Eur J Respir Dis1985; 66: 141–146.
9.
LopesADarasVCrossPARobertsonGBenyonGMonaghanJM: Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer1994; 74: 90–92.
10.
TaucherSSalatAGnantMKwasnyWMlineritschBMenzelRC: Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost2003; 89: 1098–1106.
11.
CostantiniVZacharskiLRMoritzTEEdwardsRL: The platelet count in carcinoma of the lung and colon. Thromb Haemost1990; 64: 501–505.
12.
ZeimetAGMarthCMuller-HolznerEDaxenbichlerGDapuntO: Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol1994; 170: 549–554.
13.
SilvisSETurkbasNDoscherholmenA: Thrombocytosis in patients with lung cancer. JAMA1970; 211: 1852–1853.
14.
O'KeefeSCMarshallFFIssaMMHarmonMPPetrosJA: Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol2002; 168: 1378–1380.
15.
IkedaMFurukawaHImamuraHShimizuJIshidaHMasutaniS: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol2002; 9: 287–291.
16.
HernandezEDonohueKAAndersonLLHellerPBStehmanFB: The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol2000; 78: 137–142.
17.
MonrealMFernandez-LlamazaresJPinolMJulianJFBroggiMEscolaD: Platelet count and survival in patients with colorectal cancer - a preliminary study. Thromb Haemost1998; 79: 916–918.
18.
LydenDHattoriKDiasSCostaCBlaikiePButrosL: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med2001; 7: 1194–1201.
19.
VerheulHMHoekmanKLupuFBroxtermanHJvan der ValkPKakkarAK: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res2000; 6: 166–171.
20.
FolmanCCLinthorstGEvan MourikJvan WilligenGde JongeELeviM: Platelets release thrombopoietin (Tpo) upon activation: Another regulatory loop in thrombocytopoiesis?Thromb Haemost2000; 83: 923–930.
DvorakHFBrownLFDetmarMDvorakAM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol1995; 146: 1029–1039.
23.
KumarHHeerKLeePWDuthieGSMacDonaldAWGreenmanJ: Pre-operative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res1998; 4: 1279–1285.
24.
DirixLYVermeulenPBHubensGBenoyIMartinMDePooterC: Serum basic fibroblast growth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer. Ann Oncol1996; 7: 843–848.
25.
MohleRGreenDMooreMANachmanRLRafiiS: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci US A1997; 94: 663–668.
26.
YamamotoYToiMKondoSMatsumotoTSuzukiHKitamuraM: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res1996; 2: 821–826.
27.
MaLElliottSNCirinoGBuretAIgnarroLJWallaceJL: Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A2001; 98: 6470–6475.
28.
PaulyJLSchullerMGZelcerAAKirssTAGoreSSGermainMJ: Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst1977; 58: 1587–1590.
29.
DabrowMBFrancescoMRMcBreartyFXCaradonnaS: The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol1998; 71: 29–37.
30.
TakebayashiYYamadaKMaruyamaIFujiiRAkiyamaSAikouT: The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett1995; 92: 1–7.
31.
Van TriestBPinedoHMBlaauwgeersJLvan DiestPJSchoenmakersPSVoornDA: Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res2000; 6: 1063–1072.
32.
TakebayashiRAkiyamaSAkibaSYamadaKMiyedaraKSumizawaT: Clinico-pathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst1996; 88: 1110–1117.
33.
QianXTuszynskiGP: Expression of thrombo-spondin-1 in cancer: A role in tumor progression. Proc Soc Exp Biol Med1996; 212: 199–207.
34.
ArnolettiJPAlboDGranickMSSolomonMPCastiglioniARothmanVL: Thrombo-spondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer1995; 76: 998–1005.
35.
KarpatkinSPearlsteinE: Role of platelets in tumor cell metastases. Ann Intern Med1981; 95: 636–641.
